You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

List of Excipients in API FOSAMPRENAVIR CALCIUM


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing FOSAMPRENAVIR CALCIUM

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
ViiV Healthcare Company LEXIVA fosamprenavir calcium 49702-207 CELLULOSE, MICROCRYSTALLINE
ViiV Healthcare Company LEXIVA fosamprenavir calcium 49702-207 CROSCARMELLOSE SODIUM
ViiV Healthcare Company LEXIVA fosamprenavir calcium 49702-207 FERRIC OXIDE RED
ViiV Healthcare Company LEXIVA fosamprenavir calcium 49702-207 HYPROMELLOSE
ViiV Healthcare Company LEXIVA fosamprenavir calcium 49702-207 MAGNESIUM STEARATE
ViiV Healthcare Company LEXIVA fosamprenavir calcium 49702-207 POVIDONE K30
ViiV Healthcare Company LEXIVA fosamprenavir calcium 49702-207 SILICON DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing FOSAMPRENAVIR CALCIUM

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc fosamprenavir calcium 0378-3520 CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc fosamprenavir calcium 0378-3520 CROSCARMELLOSE SODIUM
Mylan Pharmaceuticals Inc fosamprenavir calcium 0378-3520 FERRIC OXIDE RED
Mylan Pharmaceuticals Inc fosamprenavir calcium 0378-3520 HYPROMELLOSE
Mylan Pharmaceuticals Inc fosamprenavir calcium 0378-3520 MAGNESIUM STEARATE
Mylan Pharmaceuticals Inc fosamprenavir calcium 0378-3520 POVIDONE
Mylan Pharmaceuticals Inc fosamprenavir calcium 0378-3520 SILICON DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for FOSAMPRENAVIR CALCIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

FOSAMPRENAVIR CALCIUM drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Mylan Pharmaceuticals Inc fosamprenavir calcium 0378-3520
ViiV Healthcare Company fosamprenavir calcium 49702-207
State of Florida DOH Central Pharmacy fosamprenavir calcium 53808-0281
State of Florida DOH Central Pharmacy fosamprenavir calcium 53808-1010
Sun Pharmaceutical Industries Inc fosamprenavir calcium 63304-583
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: ETHYLCELLULOSE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links